Is TScan Therapeutics, Inc. (TCRX) a Buy, Sell, or Hold?
NASDAQ : TCRX
TScan Therapeutics, Inc. — Analyst Ratings
$0.767 USD
-$0.01 (-1.26%)
- Volume
- 394.02K
- Average Volume
- 829.65K
- Market Capitalization
- $46.84M
- P/E Ratio
- -0.84
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $2.57
- Year Low
- $0.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.23
Analyst Consensus Summary
Consensus Rating
Sell
8 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-89.8%
vs Current Price
Price Target
$7.50
Average TargetPrice Target Range
Lowest Target
$3.00
-74.4% DOWNSIDE
Average Target
$7.50
Median Estimate
Highest Target
$12.00
-93.6% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BTIG | Justin Zelin | $12 | $8.93 | 2024-05-16 02:44 AM | 34.4% |